There are at least 2 parties working toward trialling and scaling up immune survivor plasma therapy 1) @TakedaPharma https://t.co/igGpRGQxmg 2) @ACasadevall1 at Johns Hopkins— Hwa Shi-Hsia (IPA: /xwa/ /ʂɚ/ /ɕja/) (@coolvirus) March 27, 2020
There are at least 2 parties working toward trialling and scaling up immune survivor plasma therapy 1) @TakedaPharma https://t.co/igGpRGQxmg 2) @ACasadevall1 at Johns Hopkins